Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
AMLX
4 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in Amylyx Pharmaceuticals, Inc.
No. Farallon Capital Management exited its AMLX (Amylyx Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 1,150,221 shares worth $3.7M. Farallon Capital Management first reported AMLX in Q1 2024 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$3.3M
Total Shares Change
-1.2M
Quarter-by-Quarter History
Other major holders of AMLX: FMR LLC, Viking Global Investors LP